- £1.22bn
- £825.65m
- £639.40m
- 97
- 55
- 92
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 363 | 358 | 443 | 604 | 639 |
Cost of Revenue | |||||
Gross Profit | 349 | 345 | 427 | 582 | 609 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 362 | 373 | 373 | 504 | 540 |
Operating Profit | 1.4 | -14.7 | 70.8 | 100 | 99.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.2 | -16.4 | 69.1 | 100 | 109 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.9 | -25.8 | 54.4 | 79.6 | 85.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -12.8 | -28.9 | 50.1 | 75.6 | 83.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.8 | -28.9 | 50.1 | 75.6 | 83.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.18 | 1.05 | 1.64 | 2.49 | 2.74 |
Dividends per Share |